Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (24)

2023

  1. GRF2 Is Crucial for Cone Photoreceptor Viability and Ribbon Synapse Formation in the Mouse Retina

    Cells, Vol. 12, Núm. 21

2022

  1. Novel adcs and strategies to overcome resistance to anti-her2 adcs

    Cancers, Vol. 14, Núm. 1

2021

  1. Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins

    Haematologica, Vol. 106, Núm. 1, pp. 142-153

  2. Efficient fractionation and analysis of ribosome assembly intermediates in human cells

    RNA Biology, Vol. 18, Núm. S1, pp. 182-197

  3. Granuloma formation in a cyba-deficient model of chronic granulomatous disease is associated with myeloid hyperplasia and the exhaustion of B-cell lineage

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  4. Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling

    Methods in Molecular Biology (Humana Press Inc.), pp. 361-395

2020

  1. Antitumoral properties of the nutritional supplement ocoxin oral solution: A comprehensive review

    Nutrients, Vol. 12, Núm. 9, pp. 1-18

2019

  1. Central role of cell cycle regulation in the antitumoral action of ocoxin

    Nutrients, Vol. 11, Núm. 5

  2. Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice

    Cell Death and Disease, Vol. 10, Núm. 11

  3. TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells

    Cancer Letters, Vol. 453, pp. 34-44

  4. Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms

    Oncogene, Vol. 38, Núm. 2, pp. 209-227

2017

  1. Focal accumulation of preribosomes outside the nucleolus during metaphase-anaphase in budding yeast

    RNA, Vol. 23, Núm. 9, pp. 1432-1443

  2. Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus

    Molecular and Cellular Neuroscience, Vol. 85, pp. 127-147

  3. Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity

    Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651

2016

  1. Antitumoral effect of Ocoxin on acute myeloid leukemia

    Oncotarget, Vol. 7, Núm. 5, pp. 6231-6242

2015

  1. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 93, pp. 52-79

  2. Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions

    Molecular and Cellular Biology, Vol. 35, Núm. 20, pp. 3528-3546

2014

  1. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 Inhibition as an antimyeloma strategy

    Molecular Cancer Therapeutics, Vol. 13, Núm. 2, pp. 504-516

2012

  1. Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients

    Leukemia, Vol. 26, Núm. 8, pp. 1862-1869

2008

  1. Neuregulins and cancer

    Clinical Cancer Research, Vol. 14, Núm. 11, pp. 3237-3241